HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 271 filers reported holding HAEMONETICS CORP in Q3 2022. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,660,020 | -21.3% | 119,000 | -25.2% | 0.46% | -20.3% |
| Q2 2023 | $13,537,260 | +2.9% | 159,000 | 0.0% | 0.57% | -0.9% |
| Q1 2023 | $13,157,250 | -9.1% | 159,000 | -13.6% | 0.58% | -12.3% |
| Q4 2022 | $14,471,600 | +6.2% | 184,000 | 0.0% | 0.66% | -6.1% |
| Q3 2022 | $13,622,000 | +10.6% | 184,000 | -2.6% | 0.70% | +16.9% |
| Q2 2022 | $12,319,000 | +3.1% | 189,000 | 0.0% | 0.60% | +19.3% |
| Q1 2022 | $11,949,000 | +63.2% | 189,000 | +37.0% | 0.50% | +76.8% |
| Q4 2021 | $7,320,000 | -5.7% | 138,000 | +25.5% | 0.28% | -11.0% |
| Q3 2021 | $7,765,000 | +29.5% | 110,000 | +22.2% | 0.32% | +31.8% |
| Q2 2021 | $5,998,000 | -10.0% | 90,000 | +50.0% | 0.24% | -16.3% |
| Q1 2021 | $6,661,000 | -6.5% | 60,000 | 0.0% | 0.29% | -10.5% |
| Q4 2020 | $7,125,000 | +63.3% | 60,000 | +20.0% | 0.32% | +46.8% |
| Q3 2020 | $4,363,000 | +94.9% | 50,000 | +100.0% | 0.22% | +81.8% |
| Q2 2020 | $2,239,000 | – | 25,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LGT CAPITAL PARTNERS LTD. | 1,216,059 | $64,500,000 | 1.72% |
| HEARTLAND ADVISORS INC | 406,192 | $21,544,000 | 1.26% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $10,608,000 | 1.22% |
| Aurora Investment Counsel | 32,149 | $1,705,000 | 1.01% |
| Endurant Capital Management LP | 73,914 | $3,920,000 | 0.95% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 135,000 | $7,160,000 | 0.82% |
| ARMISTICE CAPITAL, LLC | 872,000 | $46,251,000 | 0.76% |
| Summit Creek Advisors LLC | 131,357 | $6,967,000 | 0.70% |
| Dean Capital Management | 15,309 | $812,000 | 0.70% |
| Keene & Associates, Inc. | 11,720 | $622,000 | 0.54% |